CAS: 4799-68-2; 3-(Benzyloxy)Propan-1-Ol

该化合物其结构特征为有机化合物,其特征是丙诺醇脊柱,附于第三碳的苯氧基组;该化合物一般没有色素,与黄色液体无色,由于存在氢氧(-OH)组,在水中表现出中等溶解性,同时在乙醇和乙醇等有机溶剂中也存在溶解性;苯氧基组增强了它的再活性,使其在各种化学反应(包括化)中有用,并成为有机合成中的潜在中间体;其特性包括相对低的沸点和特定密度,可因纯度和环境条件而不同. 3-(苯基氧)-1-丙醇由于其功能多功能,经常用于合成药物,农业化学品和其他精密化学品.安全数据表明,与许多有机化合物一样,应谨慎处理,使用适当的安全措施避免吸入或皮肤接触.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

2-phenyl-1,3-dioxane benzyl chloride trimethyleneglycol benzyl alcohol 1-chloro-3-benzyloxypropane 1-[(3-bromopropoxy)methyl]-benzene 1-benzyloxy-3-tosyloxypropane methyl β-benzyloxypropionate

合成工艺路线路线简述

  • 合成目标产物 3-Benzyloxy-1-Propanol 主要起始原料 Benzyl Chloride And 1,3-Propanediol
  • (文献来源)合成步骤主要原料 Benzyl Chloride 和 1,3-Propanediol
Trimethyl-[2-(3-Phenylmethoxypropoxymethoxy)Ethyl]Silane置于magnesium Bromide体系中,用 乙醚,硝基甲烷 作为反应溶剂,化学反应 5.0H,以95%的收率获得产物3-苄氧基-1-丙醇
参考文献:新型sem醚脱保护剂:使用溴化镁的非常温和且选择性的方法
标题:新型sem醚脱保护剂:使用溴化镁的非常温和且选择性的方法
摘要:通过mgbr(2)/ Et(2)o / Meno(2)脱保护方案,已为包含sem醚基的多功能底物建立了新的不稳定性和稳定性序列.
DOI:10.1021/ol0057784

海关参考信息

专利信息


专利号:US-7368568-B2
优先权日:2001-08-03
标 题 :Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for production and the use
发明人:WESTERMANN JURGEN; PLATZEK JOHANNES; PETROV ORLIN
权利人:BAYER SCHERING PHARMA AG
摘要:The invention relates to new protected 3,5-dihydroxy-2,2-dimethyl-valeroarnides for the synthesis of edothilones and derivatives and process for the production and the use of the new compounds for the production of epothilones or epothilone derivatives.

专利号:US-6933385-B2
优先权日:2001-08-03
标题 :Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for the production and the use
发明人:WESTERMANN JURGEN; PLATZEK JOHANNES; PETROV ORLIN
权利人:SCHERING AG
摘要:The invention relates to new protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for the production and the use of the new compounds for the production of epothilones or epothilone derivatives.

专利号:US-4412958-A
优先权日:1981-10-16
标 题:Stereospecific synthesis of 5-phenyl-2S-pentanol
发明人:CUE JR BERKELEY W; MOORE BERNARD S
权利人:PFIZER
摘要:5-Phenyl-2S-pentanol is synthesized stereospecifically from S ethyl lactate. The method provides easily purified 5-phenyl-2S-pentanol useful in the synthesis of central nervous system active (CNS) agents such as levonantradol.

专利号:US-7442802-B2
优先权日:2002-06-27
标 题:Cyclooxygenase-2 selective inhibitors, compositions and methods of use
发明人:BANDARAGE UPUL K; EARL RICHARD A; EZAWA MAIKO; FANG XINQIN; GARVEY DAVID S; KHANAPURE SUBHASH P; RANATUNGE RAMANI R; RICHARDSON STEWART K; SCHROEDER JOSEPH D; STEVENSON CHERI A; WEY SHIOW-JYI
权利人:NITROMED INC
摘要:The invention describes novel cyclooxygenase 2 (COX-2) selective inhibitors and novel compositions comprising at least one cyclooxygenase 2 (COX-2) selective inhibitor, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one COX-2 selective inhibitor, optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor, and/or, optionally, at least one therapeutic agent. The novel cyclooxygenase 2 selective inhibitors of the invention can be optionally nitrosated and/or nitrosylated. The invention also provides methods for treating inflammation, pain and fever; for treating and/or improving the gastrointestinal properties of COX-2 selective inhibitors; for facilitating wound healing; for treating and/or preventing renal and/or respiratory toxicity; for treating and/or preventing other disorders resulting from elevated levels of cyclooxygenase-2; and for improving the cardiovascular profile of COX-2 selective inhibitors.

专利号:US-6335458-B1
优先权日:1998-02-27
标题:Intermediate compounds in the synthesis of the A ring moiety of 2-substituted vitamin D derivatives
发明人:OGASAWARA KUNIO; TAKAHASHI MICHIYASU
权利人:CHUGAI PHARMACEUTICAL CO LTD
摘要:The object of the present invention is to provide novel compounds corresponding to the A ring part of vitamin D derivatives having a substituent at the 2-position. According to the present invention, there are provided compounds of the general formula (1):(wherein R1, R2 and R3, which may be the same or different, represent a hydrogen atom or a protecting group and R4 represents a lower alkyl group), intermediates for synthesizing them and a process for preparing them.

专利号:US-6989401-B2
优先权日:2000-07-19
标题:Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products
发明人:MAEDA KAZUHIRO; SONDA SHUJI; TAKEMOTO TADAHIRO; GOTO TOMOKAZU; KOBAYASHI FUJIO; KAJII MASAHIKO; KOMORITA NARUYASU; HIRAYAMA FUMIHIRO
权利人:MITSUBISHI PHARMA CORP
摘要:The present invention relates to a novel sulfonic acid derivative of hydroxamic acid or a pharmacologically acceptable salt thereof. More particularly, the present invention relates to a sulfonic acid derivative of hydroxamic acid or a pharmacologically acceptable salt thereof, which is useful as an inhibitor of lipopolysaccharides (LPS). In addition, the present invention relates to a novel intermediate compound useful for the synthesis of this sulfonic acid derivative of hydroxamic acid.
南京飞翔医药技术有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.chemfly.com
电话: 025-58740787👤
📞南京飞翔医药技术有限公司 ⚠️参考联系方式

销售电话:025-58740787
邮箱:info@chemfly.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
扬州市普林斯医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.princechem.cn
企业联系电话:吴宇皓18752736070,郭跃18936227980👤
📞扬州市普林斯医药科技有限公司 ⚠️参考联系方式
联系人:吴宇皓;郭跃
电话:吴宇皓18752736070,郭跃18936227980
手机:吴宇皓18752736070

邮箱:david@princechem.com;remi@princechem.com;chen@princechem.com
通信地址: 扬州市高新技术开发区吉安南路158号金荣科技园B8栋6楼
邮编: 225000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:扬州市高新技术开发区吉安南路158号金荣科技园B8栋6楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

[参考文献]: Cheng Chen, Et Al. Selective Catalytic Sp3 C-O Bond Cleavage With C-N Bond Formation In 3-Alkoxy-1-Propanols. Org Lett. 2012 Jun 15;14(12):2992-5.
[参考文献]: Douglas M Mans, Et Al. Total Synthesis Of (+)-Cocaine Via Desymmetrization Of A Meso-Dialdehyde. Org Lett. 2004 Sep 16;6(19):3305-8.

合成参考文献


摘要:Podlech, J., Science of Synthesis Knowledge Updates, (2018) 4, 137.
摘要:Margaretha, P., Science of Synthesis Knowledge Updates, (2014) 2, 437.
摘要:Arndtsen, B. A.; Tjutrins, J., Science of Synthesis: Multicomponent Reactions, (2013) 2, 517.
摘要:Sasano, Y.; Iwabuchi, Y., Science of Synthesis: Special Topics, (2022) 1, 329.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知